Vireo Growth INC 8-K filings

Vireo Growth Inc. has successfully completed a comprehensive debt refinancing, securing $153 million in new credit facilities that are expected to generate over $10 million in annual interest savings and provide more than $100 million in cash.

Vireo Growth Inc. announced that its shareholders re-elected all five director nominees and approved the appointment of Davidson & Company LLP as auditors at the Annual General Meeting held on June 20, 2025.

Vireo Growth Inc. announced the successful completion of all its merger transactions, projecting Q2 2025 pro forma revenue of $88-$91 million and adjusted EBITDA of $23-$24 million, while actively pursuing debt refinancing on more favorable terms.

Vireo Growth Inc. has successfully closed its acquisition of Deep Roots Holdings, Inc. for $132.7 million, solidifying its presence in the Nevada cannabis market and adjusting key merger agreement terms.

Vireo Growth Inc. has filed an amendment to its 8-K report, disclosing its assumption of a significant financial obligation totaling approximately $25.5 million under a Credit Agreement as a result of recent mergers.

Vireo Growth Inc. has successfully closed its previously announced acquisition of Proper Brands, a leading independent cannabis operator in Missouri, for $102 million paid in subordinate voting shares.

Vireo Growth Inc. finalizes the acquisition of WholesomeCo Cannabis and Arches technology platform, aiming to boost profitability and gain a competitive edge.

Vireo Growth Inc. announced its Q1 2025 financial results, showing a slight revenue increase and progress on pending merger transactions.

Vireo Growth Inc. has amended its merger agreements with Proper Holdings, Deep Roots Holdings, and WholesomeCo, clarifying share issuance and earn-out payment terms.

Vireo Growth Inc. modifies the terms of employment agreements for its CEO, John Mazarakis, and CFO, Tyson Macdonald, focusing on equity and incentive compensation.

Vireo Growth Inc. achieved record financial performance in 2024, driven by a 15.4% increase in revenue excluding discontinued operations and strategic growth initiatives.

Vireo Growth Inc. has extended the exclusivity period with Bills Nursery, Inc. to February 23, 2025, regarding a proposed transaction.

Vireo Growth Inc. successfully closed an oversubscribed equity offering, raising $81 million to fund growth initiatives.

Vireo Growth Inc. subsidiary, Vireo Health of Minnesota, secures $26.5 million in loans to fund expansion of its cultivation facility in Elk River, Minnesota.

Vireo Growth Inc. has announced a $75 million equity financing and the acquisition of four single-state cannabis operators, expanding its footprint to seven states.

Vireo Growth Inc. has obtained a new convertible debt facility for up to $10 million, funded by its existing senior secured lender.

Vireo Growth Inc. has announced a leadership transition with Amber Shimpa appointed as CEO and the termination of a consulting agreement with Grown Rogue Unlimited, LLC.

Vireo Growth Inc. has extended its credit agreement maturity date by 30 months and converted all outstanding convertible notes, significantly reducing interest expenses and strengthening its financial position.

Goodness Growth Holdings has officially changed its name to Vireo Growth Inc., with new ticker symbols expected to be effective on or about July 8, 2024.

Goodness Growth Holdings held its annual shareholder meeting on June 21, 2024, where all director nominees were elected and all other proposals were approved.

Goodness Growth Holdings has amended its credit facility to extend the maturity date of its delayed draw loans to July 31, 2024.

Goodness Growth Holdings reports the resignation of its Executive Vice President of Retail and grants restricted stock units to its CEO.

Goodness Growth Holdings has appointed Josh Rosen as its permanent CEO, extended its credit facility maturity date, and announced a planned corporate name change to Vireo.

Goodness Growth Holdings has announced its annual general special meeting of shareholders will be held on June 21, 2024, with key deadlines for shareholder proposals and director nominations.

Goodness Growth Holdings has agreed to sell its New York subsidiary, Vireo Health of New York, to ACE Venture Enterprises for a price between $3 million and $5 million, plus the assumption of liabilities.